These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8746100)

  • 1. [Is it still possible to reduce the incidence of nephrotoxicity of aminoglycosides?].
    Beauchamp D; Labrecque G; Bergeron MG
    Pathol Biol (Paris); 1995 Nov; 43(9):779-87. PubMed ID: 8746100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycoside nephrotoxicity: do time and frequency of administration matter?
    Beauchamp D; Labrecque G
    Curr Opin Crit Care; 2001 Dec; 7(6):401-8. PubMed ID: 11805542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aminoglycoside-induced nephrotoxicity].
    Fabrizii V; Thalhammer F; Hörl WH
    Wien Klin Wochenschr; 1997 Nov; 109(21):830-5. PubMed ID: 9454436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycosides: assessing the potential for nephrotoxicity.
    Wilson SE
    Surg Gynecol Obstet; 1990; 171 Suppl():24-30. PubMed ID: 2244292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do we still need the aminoglycosides?
    Durante-Mangoni E; Grammatikos A; Utili R; Falagas ME
    Int J Antimicrob Agents; 2009 Mar; 33(3):201-5. PubMed ID: 18976888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is it possible to reduce the incidence of aminoglycoside-induced nephrotoxicity?].
    Fillastre JP
    Bull Acad Natl Med; 1999; 183(5):973-82; discussion 983. PubMed ID: 10465001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients.
    Prins JM; Weverling GJ; van Ketel RJ; Speelman P
    Clin Pharmacol Ther; 1997 Jul; 62(1):106-11. PubMed ID: 9246024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and risk factors of colistin-induced nephrotoxicity.
    Kim J; Lee KH; Yoo S; Pai H
    Int J Antimicrob Agents; 2009 Nov; 34(5):434-8. PubMed ID: 19726164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ototoxicity of aminoglycoside antibiotics].
    Reiss M; Reiss G
    Praxis (Bern 1994); 2003 Jan; 92(4):127-33. PubMed ID: 12632843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of aminoglycosides in the intensive care unit.
    Radigan EA; Gilchrist NA; Miller MA
    J Intensive Care Med; 2010; 25(6):327-42. PubMed ID: 20837630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the evidence for once-daily aminoglycoside therapy?
    Barclay ML; Begg EJ; Hickling KG
    Clin Pharmacokinet; 1994 Jul; 27(1):32-48. PubMed ID: 7955770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aminoglycosides].
    Palomino J; Pachón J
    Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):105-14; QUIZ 115, 120. PubMed ID: 12586036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside nephrotoxicity: recent developments.
    Walker R
    N Z Med J; 1994 Feb; 107(972):54-5. PubMed ID: 8115070
    [No Abstract]   [Full Text] [Related]  

  • 14. Aminoglycoside nephrotoxicity.
    Swan SK
    Semin Nephrol; 1997 Jan; 17(1):27-33. PubMed ID: 9000547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aminoglycoside toxicity. Pathomechanisms, clinical management and means of prevention].
    Lautermann J; Schacht J; Jahnke K
    HNO; 2003 Apr; 51(4):344-51; quiz 352. PubMed ID: 12682739
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aminoglycosides in pediatrics].
    Schaad UB
    Schweiz Med Wochenschr Suppl; 1996; 76():34S-38S. PubMed ID: 8677417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotoxicity of aminoglycosides and cephalosporins in combination.
    Rankin GO; Sutherland CH
    Adverse Drug React Acute Poisoning Rev; 1989; 8(2):73-88. PubMed ID: 2672726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended dosage intervals for aminoglycosides.
    Rodman DP; Maxwell AJ; McKnight JT
    Am J Hosp Pharm; 1994 Aug; 51(16):2016-21. PubMed ID: 7977422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Aminoglycoside antibiotics.
    Horrevorts AM; Driessen OM; Michel MF; Kerrebijn KF
    Chest; 1988 Aug; 94(2 Suppl):120S-125S. PubMed ID: 3293937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.